|Aegis Capital||Nathan Weinstein, CFAfirstname.lastname@example.org|
|B. Riley FBR, Inc.||George B. Zavoico, Ph.D.||email@example.com|
|Echelon Wealth Partners||Douglas Loefirstname.lastname@example.org|
|H.C. Wainwright & Co.||Andrew S. Feinemail@example.com|
|Mackie Research||André Uddin, Ph.D.||firstname.lastname@example.org|
|Oppenheimer & Co. Inc.||Leland Gershell, MD, PhD||212-667-7189||Leland.Gershell@opco.com|
Acasti Pharma Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Acasti Pharma Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Acasti Pharma Inc. or its management. Acasti Pharma Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.